HotSpot Therapeutics
Biotechnology company developing medicines that target allosteric regulatory sites on proteins
3
Funding Rounds
$210.0m
Money raised
Overview
Biotechnology company developing medicines that target allosteric regulatory sites on proteins
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company HotSpot Therapeutics has raised a total of $210m in funding over 3 rounds.
Key Insights:
- Hotspot Therapeutics Series C round, November 2021: $100m
- Hotspot Therapeutics Series B round, May 2020: $65m
- HotSpot Therapeutics Series A round, July 2018: $45m
Hotspot Therapeutics Series C round, November 2021
$100m
Hotspot Therapeutics Series B round, May 2020
$65m
HotSpot Therapeutics Series A round, July 2018
$45m
Industries
HotSpot Therapeutics is active in the following industries: